Syros Pharmaceuticals Inc (SYRS) Down 3.31% in Premarket Trading

Syros Pharmaceuticals Inc (SYRS) has fallen Thursday morning, with the stock losing -3.31% in pre-market trading to 6.43. SYRS's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 122 out of 146 industries, SYRS ranks higher than 0% of stocks. Syros Pharmaceuticals Inc has fallen 17.49% over the past month, closing at $8.90 on August 25. During this period of time, the stock fell as low as $6.08 and as high as $9.43. SYRS has an average analyst recommendation of Strong Buy. The company has an average price target of $96.00.

SYRS has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on SYRS!

See Full SYRS Report

Syros Pharmaceuticals Inc has a Long-Term Technical rank of 55. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 45% of the market scoring higher. In the Biotechnology industry which is number 54 by this metric, SYRS ranks better than 54% of stocks.

Important Dates for Investors in SYRS:

-Syros Pharmaceuticals Inc is set to release earnings on 11/4/2022. Over the last 12 months, the company has reported EPS of $-17.20. -We do not have a set dividend date for Syros Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Syros Pharmaceuticals Inc (SYRS)